The Changing Policy Landscape Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms
“The two traditional means by which pharmaceutical marketers haverelied on for many, many years to encourage the uptake of newpharmaceutical products — direct-to-consumer (DTC) advertising and physicianmarketing — are about to change,” warned Mark S. Senak, J.D., SVP,Fleishman-Hillard and author of Eye On FDA Blog, in a presentation at the recent DTCin the Era of Consumer Choice conference.
Senak summarized allthe possibly policy changes coming down the pike that will specificallyimpart pharmaceutical marketing. He also suggests what the industryshould be doing to meet these challenges.
This article is summarizes Senak’s presentation, which he later expanded upon in a YouTube video.
Topic headings include:
- Changes Ahead for DTC Marketing
- Adverse Event Reporting Info in TV Ads
- Drug Safety
- Pricing Pressure
- Changing Communications Landscape
- Suggestions for Action
- Overcoming Regulatory Roadblocks
Read this article now. It’s FREE…
Issue: Vol. 7, No. 10: December 2008
Word Count: 2777